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Abstract
Wide-spread protozoan parasites carry endosymbiotic dsRNA viruses with uncharted implications to the human host.
Among them, Trichomonas vaginalis, a parasite adapted to the human genitourinary tract, infects globally ,250 million
each year rendering them more susceptible to devastating pregnancy complications (especially preterm birth), HIV infection
and HPV-related cancer. While first-line antibiotic treatment (metronidazole) commonly kills the protozoan pathogen, it fails
to improve reproductive outcome. We show that endosymbiotic Trichomonasvirus, highly prevalent in T. vaginalis clinical
isolates, is sensed by the human epithelial cells via Toll-like receptor 3, triggering Interferon Regulating Factor -3, interferon
type I and proinflammatory cascades previously implicated in preterm birth and HIV-1 susceptibility. Metronidazole
treatment amplified these proinflammatory responses. Thus, a new paradigm targeting the protozoan viruses along with
the protozoan host may prevent trichomoniasis-attributable inflammatory sequelae.
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Introduction
A number of parasitic protozoan genera (Trichomonas, Leishmania,
Giardia, Plasmodium, Entamoeba, Naegleria, Eimeria, Cryptosporidum,
Babesia) carry endosymbiotic dsRNA viruses considered noninfec-
tious for, but with unknown pathologic consequences to, the
vertebrate/human host [1]. Among those virus-inhabited para-
sites, Trichomonas vaginalis (TV) is perhaps the most ubiquitously
spread worldwide [2]. It is an obligatory extracellular parasite of
the human genitourinary tract and the most common infectious
cause of vaginitis and reproductive tract problems [3]. In 2005
alone it infected 248 million men and women worldwide,
accounting for more than half of the 448 million new cases of
the four main non-viral sexually transmitted infections (STIs)
(chlamydiasis, gonorrhoea, syphilis, and trichomoniasis) [4].
Sensitive PCR detection techniques show an even more astound-
ing prevalence of TV e.g. 50% or more in some urban centers of
the United States [5]. The TV infection frequently recurs and
coincides with a disturbed vaginal microflora syndrome, known as
bacterial vaginosis (BV), and an increased susceptibility to other
STIs, especially human immunodeficiency virus (HIV) and human
papillomavirus (HPV), and associated cervical and prostate
cancers [6,7,8,9,10,11]. An estimated 746 annually-acquired
HIV cases among women, with lifetime cost of $167 million,
can be attributed to the facilitative effects of trichomoniasis [12].
Unfortunately, despite antibiotic treatments available for over
50 years, trichomoniasis remains associated with staggering social,
economic, and medical burdens, especially for women and
children. The reproductive complications of TV infection include
pelvic inflammatory disease, tubal infertility, pregnancy loss,
premature membrane rupture, preterm delivery, low birth weight,
and mother-to-child TV transmission (reviewed in [3]). The costs
associated with preterm birth in the United States alone escalated
to $26.2 billion in 2005 (http://www.nas.edu/morenews/
20060713.html). Inflammatory damage and immune dysregula-
tion have been blamed for these complications [3].
Metronidazole, an antibiotic of the nitromidazole class, is the
first-line treatment for trichomoniasis in the USA and in most
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e48418parts of the world. The most recent Cochrane review of
randomized clinical trials of trichomoniasis treatment during
pregnancy indicated that while metronidazole is effective at
achieving parasite clearance when properly administered, it is
likely to cause harm and does not improve the pregnancy outcome
or the prognosis for complications in the pre-term newborns [4].
An extensive search of Pre-Medline, Medline (1966–1983),
EMBASE (1980–2003) and the Cochrane Library and metaana-
lysis of 14 eligible randomized control trials concluded that
antibiotic treatment in women with BV reduced the risk of
persistent infection but not the risk of preterm birth and in women
with trichomoniasis, metronidazole reduced the risk of persistent
infection but increased the risk of preterm birth [13]. In addition,
TV resistance to metronidazole is rising [14], and requires use of
higher doses with more significant side effects, possible selection of
more resistant strains, and in fact, some patients remain incurable
[15,16]. Clearly, desperately needed is a paradigm shift to better
preventative and therapeutic modalities, desirably focused on host
immunity and anti-virulence measures beyond conventional anti-
parasitic medication.
At least half of the primary clinical isolates of TV persistently
carry TV-specific, dsRNA viruses (TVVs) from the newly
recognized genus Trichomonasvirus of the family Totiviridae
[2,17,18,19,20,21]. These endosymbionts are generally noncyto-
pathic to the protozoan host [1], possibly contributing to its
adaptation to and virulence for the obligatory human host. We
hypothesized that although TVVs similarly to other protozoan
viruses might not replicate in the human host cells, their genomic
dsRNA, gene products or whole virions shed by the parasites can
be sensed by the human cells and thereby contribute to
inflammatory complications in the course of TV infection and/
or routine antibiotic treatment. Toward testing this paradigm-
shifting hypothesis, we recruited symptomatic women attending
STI clinics to collect virulent vaginal TV isolates, and applied an
in-vitro model of the female genital mucosa [22,23] to study the
effects of TVV positive strains and purified TVV virions on the
immuno-inflammatory responses of the human cervicovaginal
epithelium in the presence or absence of metronidazole. The
results support the concept of protozoan viruses acting as
pathogenic modifiers of the human innate immunity and
amplifiers of inflammatory responses and provide the rationale
for further clinical investigations toward the discovery of new
targets of anti-virulence therapies and prevention of complications
from parasitic disease.
Materials and Methods
Ethics Statement
Patient recruitment and the research involving vaginal sample
collection for this study occurred with written informed consent
and protocols approved by the Institutional Review Boards of both
SUNY Upstate Medical University, Syracuse, NY and Brigham
and Women’s Hospital, Boston, MA according to the principles
expressed in the Declaration of Helsinki.
Reagents
Metronidazole was purchased from Acros Organics (Fair Lawn,
NJ) and bafilomycin A1 from Sigma (Saint Louis, MO). MALP-2
(Enzo Life Sciences, Farmingdale, NY) was used at 25 nM and
poly(I:C) (Invivogen, San Diego, CA) at 10 mg/ml. All reagents
were endotoxin free according to manufacturer and in-house
preparations were confirmed negative using the EndoSafe Test
System (Charles River Laboratories, Charleston, SC, USA) based
on the Limulus Amoebocyte Lysate test with sensitivity
,0.05 EU/mL as previously described [23].
Epithelial Cell Culture
Human immortalized endocervical (End1/E6E7), ectocervical
(Ect1/E6E7) and vaginal (Vk2/E6E7) epithelial cell lines, were
grown in KSFM (Invitrogen, Carlsbad, CA) modified as described
[24]. Stable End1/E6E7 derivatives were obtained by co-
transfection with zeocin-resistance plasmid and pDeNy-hTRIF
(lacks TIR N- and C-terminal) or pDeNy-mcs (InvivoGen) [22].
End1/E6E7 were also stably transfected with pHTS-NF-kB firefly
luciferase reporter vector containing a hygromycin resistance gene
(Biomyx Technology, San Diego, CA) [23]. VEC-100
TM tissues
(MatTek, Ashland, MA) were handled as described [25]. All
experiments were performed under anaerobic conditions (Mitsu-
bishi AnaeroPack, Fisher) mimicking the vaginal microenviron-
ment [26].
TV Isolates and LPG Preparation
TV isolates were obtained from 34 symptomatic women at the
Onondaga County Health Department STI Clinic (OC isolates)
and the University Hospital Microbiology/Clinical Pathology Lab,
SUNY Upstate Medical University (UH isolates), Syracuse, NY.
The UR-1 isolate was obtained from the University of Rochester
STI Clinic, Rochester, NY. Vaginal swabs were placed in In-
Pouch overnight and cultured in Diamond’s trypticase-yeast
extract-maltose medium (DTYM) (pH 6.0) with 10% heat-
inactivated HyClone horse serum at 37uC. Isolates were expanded
for 2–9 passages and characterized for presence of TVV by RT-
PCR, Western Blot and sequencing [17]. For epithelial coculture
experiments, TV were harvested in late log phase (24 h) by
centrifugation at 1000 g at 21uC for 5 minutes, washed twice with
phosphate-buffered saline (PBS) (pH 7.4) and resuspended in
KSFM at 4610
5/ml. LPGs with mass-spectrometry proven purity
were isolated from the UR1 and OC6 as described [23].
Metronidazole Susceptibility
Serial dilutions (0.36 mM to 1600 mM) were made in DTYM
from metronidazole dissolved in DMSO. Equivalent DMSO
dilutions in DTYM served as vehicle control. Each solution was
mixed with 1.5610
4 trichomonads in round bottom 48-well plates,
incubated at anaerobic conditions for 24 h–48 h and examined
under inverted microscope to determine MIC [27].
TVV Virion Purification
UH9 TVV1 virions were purified following a protocols by
Bessarab et al [20] with some modifications. UH9 grown in iron-
supplemented DTYM to late exponential phase was harvested by
centrifugation (1500 g; 15 min; room temperature), resuspended
in high-salt buffer (2.15 M NaCl; 10 mM NasP04, pH 7.2)
containing protease inhibitor cocktail (Roche Diagnostics), soni-
cated on ice. Cell debris was removed by centrifugation (10,000 g;
30 min, 4uC) and the lysate was pelleted through a 40% sucrose
cushion (230,000 g; 2 h; 4uC). The virion pellet was resuspended
in HN buffer (50 mM HEPES, pH 7.2; 0.5 M NaCl) and banded
on a CsCl gradient (r=1.25 to 1.53 g/cm
3) (260,000 g; 18–24 h;
4uC). Virion fractions were identified by protein gel electropho-
resis and dialyzed with HN buffer with 20 mM MgCl2 overnight
at 4uC. The purified virions were examined by transmission
electron microscopy after negative staining with uranyl formate to
confirm the overall quality and consistency of each preparation.
Virion concentrations were estimated by BioRad protein assay
against a bovine serum albumin standard and assuming 120 capsid
Endobiont Protozoan Viruses Impact the Human Host
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280uC until use.
Cell Viability Assays
Epithelial cell viability was assessed by the CellTiter 96 3-4,5-
dimethylthiazol-2,5-diphenyltetrazolium bromide (MTT) assay
(Promega, Madison, WI) [26]. Viable T. vaginalis was enumerated
using hemocytometer and a trypan blue exclusion assay.
NF-kB Luciferase Assay
The pHTS-NF-kB luciferase reporter cell line was grown to
confluence in 96-well plates. Upon stimulation/infection the
epithelial monolayers were lysed in GloLysis buffer (80 ml/well)
for 5 minutes and mixed with equal volumes of Bright-Glo
substrate (Promega) followed by immediate luminescence reading
[23]. The lack of cytopathic effect under each treatment condition
was determined under invert microscope or in parallel cultures by
MTT.
Measurement of Soluble Immuno-inflammatory
Mediators
Concentrations of cytokines and chemokines in cell culture
supernatants were measured by multiplex electrochemilumines-
cence assays validated against ELISA [28] and Sector Imager
2400 (Meso Scale Discovery, Gaithersburg, MD). SLPI was
measured by Quantikine ELISA (R&D Systems, Minneapolis,
MN) [26]. The data were presented as pg/ml extrapolated from
calibration curves in each immunoassay and in some experiments
fold change over medium control was computed to allow
simultaneous comparisons in multiple models under conditions
of genetically or pharmacologically suppressed TLR3/TRIF
signaling.
Nuclease Protection Assay for Multiplex mRNA
The qNPA is based on hybridization of target mRNA sequences
to single-stranded antisense probes so that only gene-specific
mRNA is protected from nuclease digestion [29]. TLR expression
was examined by a custom-designed luminescence multiplex
qNPA (High Throughput Genomics, Tucson, AZ). Epithelial cells
were stimulated/infected in 96-well plates and lysed in HTG
buffer and qNPA performed as detailed [30], with TLR mRNA
normalized to two house-keeping genes and a plant gene serving as
a S1 nuclease control. HEK293 cells (TLR-Null, TLR2-6 and
TLR4) (Invivogen) served as expression controls. The target
sequences for the qNPA probes are provided in Table S1.
RNAse III Treatment
ShortCut RNase III was obtained from New England BioLabs,
Ipswich, MA. To establish the effectiveness of this enzyme under
our culture conditions, aliquots of purified TVV dsRNA were
mixed with various doses of the enzyme prepared in the buffer
provided by New England BioLabs, our in-house modified
Diamond medium or KSFM and incubated for 5 min at 37uC
followed by agarose gel electrophoresis performed as described
[17]. UH9 virions, purified as described above, were added at a
concentrations of 1.0E+12 virions/ml TVV to RNAse III at the
final concentrations of 200 U/ml, 20 U/ml, 2 U/ml, or 0.2 U/
ml. In order to compare the efficiency of the enzyme to digest
naked versus capsid protected dsRNA, half of the virions were pre-
treated at 65uC for 5 min to intentionally release the dsRNA prior
to the reaction. After 5 min incubation with the enzyme at 37uC,
the reaction was quenched by EDTA buffer provided by New
England BioLabs per manufacturer’s instructions, heated for
5 min to release protected dsRNA from the capsid, and analyzed
on agarose gel. Epithelial cells were treated with poly(I:C) (10 mg/
ml), medium control or cell-free supernatants collected from a
TVV-negative (B7RC2) or a TVV-positive (UH9) isolate after
24 h exposure to metronidazole (100 mM) or DMSO solvent
control in KSFM. After 24 h treatment, the cell culture
supernatants were analysed for IFNb as described above.
Detection of IRF3 Phosphorylation by Western Blot
Epithelial cells were grown in 6-well plates until reaching at least
70% confluence, then stimulated as described with UH9-TVV
virions, trichomonad suspensions, cell-free trichomonad superna-
tants or supernatants from epithelial cells for 1 to 5 hours.
Poly(I:C) (10 mg/ml) and plain KSFM cell culture medium served
as a positive and negative control, respectively. Following
stimulation, the cell monolayers were placed on ice, washed in
PBS and lysed in 125 mL cold Tris lysis buffer containing
phosphatase and protease inhibitors (Meso Scale Discovery,
Gaithersburg, MD). Protein levels in lysates were measured by
Pierce BCA assay (Thermo Scientific, Rockford, IL) and Victor
2
reader (Perkin Elmer, Boston, MA). Western blot was performed
on Mini-PROTEAN II Cell system (Bio-Rad Laboratories,
Hercules, CA) as described [31]. In brief, lysates adjusted to
equal protein levels were electrophoresed on 10% SDS-polyacryl-
amide gel and transferred to PVDF membrane. Membranes were
then blocked overnight at 4C in 5% non-fat milk, 10 mM
TrisHCL, 100 mM NaCL, 0.1% Tween 20 at pH 7.4. Primary
antibodies were incubated for 1 h at RT. Membranes were
washed in the blocking buffer four times and incubated with
secondary antibodies for one hour at room temperature followed
by four washes. The following antibodies were used: rabbit
monoclonal anti-IRF3 (phospho S386) antibody [EPR2346]
(ab76493) from Abcam (Cambridge, MA), diluted 1:10,000,
mouse monoclonal anti-beta-actin AC-15 (1:5000) (Sigma Al-
drich), goat anti-rabbit and goat anti-mouse HRP-conjugated IgG
(H + L) polyclonal antibodies (1:2500), the latter two from Thermo
Scientific, Pierce, Rockford, IL. HRP-conjugated antibodies were
visualized through autoradiography using SuperSignal West Pico
Chemiluminescent substrate (Thermo Scientific, Pierce Biotech-
nology Inc.).
Statistical Analysis
Two-way ANOVA with Bonferroni post-tests was applied for
multiple comparisons matched by treatment (GraphPad 5.00, San
Diego, CA). Each statistically significant finding was reproduced in
multiple independent experiments performed in duplicate, tripli-
cate or quadruplicate cultures.
Figure 1. Trichomonasvirus positive T. vaginalis isolates (UR1, UH9) induce Type-1 Interferon and elevated proinflammatory
responses as compared to virus-free (B7RC2) protozoa and purified lipophosphoglycan (UR1-LPG). Endocervical (A–D), ectocervical (F–
I) and vaginal (E, G) epithelial cells were exposed to trichomonad isolates, LPG or poly(I:C) for 24 h. Ectocervical immortalized cell monolayers (F,G)
and the apical surface of primary polarized tissues grown on dual-compartment filters (H,I) were treated side-by-side. NF-kB-driven luciferase activity
was assessed in cell lysates and soluble mediators were measured in monolayer supernatants or apical and basal compartments. Bars are means and
S.E.M. from quadruplicate (A,C, F), triplicate (H,I) or duplicate cultures (D,E,G) representing one of at least three independent experiments. *p,0.05,
**p,0.01 and ***p,0.001, different from medium (one-way ANOVA, Bonferroni).
doi:10.1371/journal.pone.0048418.g001
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PLOS ONE | www.plosone.org 4 November 2012 | Volume 7 | Issue 11 | e48418Figure 2. Trichomonasvirus (TVV)-positive protozoa upregulate TLR3 and trigger endosomal acidification-dependent inflammatory
responses. (A, B) TLR mRNA levels were measured by a multiplex nuclease protection assay in the endocervical epithelial cells (A) and in TLR-Null or
TLR2/6+ or TLR4+ HEK293 cells (B). The endocervical cells were exposed to TVV-positive (UR1) and TVV-negative (B7RC2) trichomonad isolates, MALP-
2, poly(I:C) or LPG for 24 h. **p,0.01, ***p,0.001 different from medium (two-way ANOVA, Bonferroni). (C) Levels of NF-kB-driven luciferase in cell
lysates and IL-8 and IFNb in culture supernatants were measured 12 h post stimulation in the presence or absence of endosomal acidification
inhibitor bafilomycin A1 (BFA). (D) a multiplex immunoassay was applied to measure RANTES, IL-6 and MIP-3a in the same culture supernatants.
+++p,0.001, treatment different from medium control ***p,0.001, bafilomycin A different from solvent (DMSO) control (two-way ANOVA,
Bonferroni). Bars are means and S.E.M. of triplicate (for NF-kB) or duplicate (for cytokines) cultures representative of at least three independent
experiments.
doi:10.1371/journal.pone.0048418.g002
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Cervicovaginal Innate Immune Responses in the Context
of TVV Infection
To generate initial experimental evidence of immuno-inflam-
matory responses in the context of TVV-infection, we first tested a
clonally purified stock of a well-characterized TV isolate (UR1),
which expresses a pathogenic protozoan lypophosphoglycan (LPG)
[22,23] and is simultaneously infected with three distinct TVV
species (TVV1, TVV2, and TVV3) [2,17]. Since T. vaginalis is an
obligate human parasite thus limiting the relevance of animal
models, to test our hypothesis we used human epithelial culture
models representing the natural TV host cells in the three mucosal
compartments (uterine endocervix, ectocervix and vagina) that
guard the upper reproductive tract from ascending infections
[3,32]. Epithelial cells were simultaneously exposed for 24 h to
UR1, autologous LPG, a well-characterized TVV-negative TV
isolate (B7RC2, ATCC 50167) [17], which was used to draft the
TV genome [33], or the synthetic dsRNA analog poly(I:C). In
some experiments, we compared UR1 to another characterized
TVV-positive TV isolate (UH9), which carries only one TVV
species (TVV1) [17]. Immortalized epithelial cell lines, which
closely resemble differentiation patterns and immune responses of
their normal tissues of origin [22,24,26,34,35,36,37] were com-
pared to their primary cell counterparts in bioengineered 3-
dimensional tissues grown on permeable membrane support
(VEC-100
TM) [25,38] to confirm the physiologic relevance of
our in-vitro model.
At a noncytopathic multiplicity of infection (MOI,10) UR1
and UH9, similarly to poly(I:C), caused a proinflammatory
activation simultaneously assessed by a nuclear factor kB (NF-
kB)-driven luciferase (Fig. 1a) and levels of the chemokine
interleukin (IL)-8 (Fig. 1b). UR1, UH9 and (poly)I:C also triggered
interferon (IFN)b, a cytokine specific for anti-viral responses [39]
in all three epithelial cell types (Fig. 1c,e,f). In contrast, the TVV-
negative trichomonads at the same MOI failed to upregulate NF-
kB, IL-8 or IFNb. As expected, LPG alone caused NF-kB
activation and IL-8 upregulation [22,23], but it did not increase
IFNb levels. LPG and all TV isolates, caused a similar reduction of
the major mucosal antimicrobial factor, secretory leukocyte
protease inhibitor (SLPI) (Fig. 1d), indicating a comparable
TVV-independent virulence attributable to TV protease activities
[40] and/or LPG (novel finding).
A side-by-side comparison of the immortalized cells and the
VEC-100
TM apical secretions, showed similar IL-8 and IFNb
stimulation profiles derived from both models of the normal
human ectocervical epithelium (Fig. 1f–i). These comparisons
confirmed previously reported physiological similarities between
the same immortalized and primary cell models [22,23,26], thus
allowing us to choose the immortalized cell lines for further
experimentation, as they are significantly cheaper, more repro-
ducible, sensitive, and easier to handle in a high-throughput
setting.
The side-by-side comparison between the cell lines originating
from the three different mucosal compartments showed that the
simple columnar epithelial cells from the inside of the cervical
canal (End) were higher responders to the TVV-positive TV and
poly(I:C) as compared to the cells representing the stratified
Figure 3. TLR-3-dependent proinflammatory activation is a
common trait for Trichomonasvirus(TVV)-infected T. vaginalis
isolates. (A–C)T h ee n d o c e r v i c a lN F - kBr e p o r t e rc e l ll i n ew a s
challenged for 24 h with TVV positive or TVV negative trichomonads,
poly(I:C), MALP-2 or LPG from trichomonas isolates UR1 and OC6 in the
presence or absence of bafilomycin A (endosomal acidification inhibitor
and known TLR3 antagonist) followed by luciferase, IL-8 and IFNb
measurements. (D) IL-8 was measured in supernatants from endocer-
vical cells expressing dominant negative (dn)TRIF or control (mcs)
plasmid and infected or stimulated under the same conditions. Bars are
means and S.E.M. from duplicate cultures in two experiments. Fold
change is computed over the average obtained for the medium solvent
control. ***p,0.001, bafilomycin A1-treated or dnTRIF different from
solvent or plasmid (mcs) control, respectively;
+p,0.05 and
+++p,0.001,
infection/TLR ligand/LPG different from medium control (two-way
ANOVA, Bonferroni).
doi:10.1371/journal.pone.0048418.g003
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has been previously shown for other inflammatory conditions
[34,41]. UR1 increased IL-8 levels ,20-fold over uninfected
(medium) control in the End (Fig. 1b) and ,12-fold in the Vk
(Fig. 1g) and Ect cells (Fig. 1g). The endocervical IFNb production
was .3-fold higher than the vaginal and .5-fold higher than the
ectocervical IFNb production (Fig. 1 c, e, f). Of note, the
endocervical and ectocervical cell lines have been generated from
the same patient eliminating genetic background variations in cell
type specific responses [24]. Therefore, we chose for further
genetic reporter and pharmacologic analyses the endocervical cell
line as a prototype mucosal gate keeper of the upper reproductive
tract.
TLR3-Mediated Mechanisms of TVV Signaling to the
Human Host
The induction of IFNb by the TVV-positive UR1 and UH9 TV
isolates indicated the involvement of the epithelial virus-sensing
machinery, which includes a number of cytosolic pathogen
recognition receptors and endosomal transmembrane TLRs
[42]. We hypothesized that in the expected absence of a
productive viral infection of the human cells by Trichomonasvirus,
the TVV dsRNA genome might not have a natural infection-
mediated access to the cytosolic compartment, but it might yet be
endocytosed to enter the central vacuolar system and thus be
sensed by endosomal TLR3, which specializes in dsRNA
recognition.
To test this possibility, we first assessed the expression of TLRs
under stimulated/infected and control conditions (Fig. 2a). It has
been previously shown by RT-PCR and flow cytometry that the
human vaginal and cervical epithelial cells are deficient in TLR4
and do not respond to ultra pure bacterial LPS [36,43]; however,
TLR expression under conditions of TV infection has not been
investigated. In this study we used a multiplex quantitative
nuclease protection assay (qNPA) validated against RT-PCR [44]
to circumvent dependence on total RNA isolation and normali-
zation, which would be confounded by genomic TVV load in a
conventional RT-PCR. In the absence of stimulation the epithelial
cells expressed relatively low TLR2 and TLR6, higher levels of
TLR3 and, as previously shown [36], no TLR4. TLR2
upregulation was induced by UR1, poly(I:C) and the TLR2/6
ligand macrophage-activating lipopetide-2 (MALP-2). TLR3 was
upregulated by UR1 and poly(I:C) and downregulated by LPG.
TLR4 remained undetectable under all stimulation/infection
conditions. The TVV negative isolate B7RC2 had no significant
effects on TLR expression. To confirm that the lack of TLR4
expression and the relatively low baseline TLR2/6 expression by
the cervical cells were not an artifact of the multiplex qNPA, we
tested in parallel TLR-Null 293 cells bioengineered to express
either TLR2/6 or TLR4 (Fig. 2b).
Figure 4. The cell-free culture phase of metronidazole treated TVV-positive trichomonads enhanced TLR3/TRIF-depedent
proinflammatory responses. (A–H) Endocervical cells expressing dominant negative (dn)TRIF or control mcs plasmid were exposed to cell free
supernatants from trichomonads treated with 100 mM metronidazole for 24 h in the presence or absence of bafilomycin A1, followed by viability
assessment via MTT assay (A) and cytokine measurement in the cell culture supernatants (B–H). Data are means and S.E.M. from duplicate cultures in
one of three independent experiments.
xp,0.05,
xxxp,0.001, trichomonad supernatant different from medium (med.);
+p,0.05,
+++p,0.001,
metronidazole different from ‘no drug’; *p,0.05, p,0.001***, bafilomycin A1 plus metronidazole different from metronidazole alone; dnTRIF
different from plasmid control (two-way ANOVA, Bonferroni).
doi:10.1371/journal.pone.0048418.g004
Figure 5. The cell-free culture phase of metronidazole-treated TVV-positive trichomonads enhances TLR3-depedent IFNb
production. Endocervical were exposed to cell-free supernatants from trichomonads treated with 100 mM metronidazole for 24 h in the presence or
absence of bafilomycin A1. Data are means and S.E.M. from duplicate cultures in one of three independent experiments.
xxxp,0.001, ‘no drug’
trichomonad supernatant different from medium (med.);
+++p,0.001, metronidazole different from ‘no drug’; p,0.001***, bafilomycin A1 plus
metronidazole different from metronidazole alone; (two-way ANOVA, Bonferroni).
doi:10.1371/journal.pone.0048418.g005
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lated in the presence of TVV-infected trichomonads, we
attempted to block TLR3 signaling in our infection model
applying a dual experimental approach (Fig. 2c and Fig. 3).
First we performed experiments in the presence of bafilomycin
A1 (BFA), an antibiotic that does not inhibit the endocytotic
pathways but effectively inhibits endosomal acidification essential
for TLR3 signaling [45]. Poly(I:C), a TLR3 ligand, and MALP-2,
an endosome-independent TLR2/6 ligand, served as a positive
and negative control, respectively, for BFA activity. As shown in
Fig. 2c, after a 12 h exposure to endocervical epithelial cells, UR1
and UR1-LPG but not B7RC2 induced NF-kB, IL-8 and IFNb
patterns similar to those demonstrated in Fig. 1a, b, and c. The
UR1 trichomonads induced higher proinflammatory responses as
compared to LPG alone (p,0.001). Poly(I:C) and MALP-2
induced comparable NF-kB activation and IL-8 levels. As
expected MALP-2 did not trigger IFNb and BFA inhibited UR1
and poly(I:C) only.
We then used a multiplex immunoassay to simultaneously
measure in the same cell culture supernatants more prototypic
virus stress-inducible gene products (VSIG) e.g. IL-6 and CCL5
(known as RANTES, Regulated upon Activation, Normal T-cell
Expressed, and Secreted), commonly triggered by viruses,
interferons and dsRNA in human host cells [46]. We also
measured macrophage inflammatory protein (MIP)-3a (CCL20),
known to be upregulated by UR1-LPG along with IL-8 [22,23].
Figure 6. Metronidazole treatment of infection by TVV-positive trichomonads enhances TLR3/TRIF-depedent proinflammatory
responses. (A–H) Endocervical cells expressing dominant negative (dn)TRIF or control mcs plasmid were exposed to TVV-positive (OC6) or TVV-
negative (B7RC2) trichomonads in the presence or absence of 100 mM metronidazole for 24 h followed by multiplex measurement of levels of all
soluble mediators except IFNb which was measured in a separate assay of the same cell culture supernatants. Data are means and S.E.M. from
duplicate cultures in one of three experiments. Fold change is over medium control baseline in the absence of both drug and trichomonas. The
difference between metronidazole-treated and no drug-treated OC6 is denoted by numeric p values (p,0.001);
xxp,0.01and
xxxp,0.001, OC6
infection different from respectful medium control; *p,0.05 and ***p,0.001, dnTRIF different from plasmid (mcs) control (two-way ANOVA,
Bonferroni).
doi:10.1371/journal.pone.0048418.g006
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PLOS ONE | www.plosone.org 10 November 2012 | Volume 7 | Issue 11 | e48418The results (Fig. 2d) showed that similarly to IFNb, RANTES
was induced by UR1 and poly(I:C) only; IL-6 was amplified by
UR1 and poly(I:C) and to lesser level by MALP-2; and MIP-3a
was stimulated by UR1, LPG, poly(I:C) and MALP-2. The
production of these mediators was unaffected by B7RC2. Again,
BFA reduced only the proinflammatory responses stimulated by
UR1 and poly(I:C), indicating endosomal TLR signaling.
To confirm a ubiquitous involvement of TLR3 signaling in the
context of TVV-infection, we surveyed additional primary TV
isolates and this time applied not only pharmacologic blockade by
BFA (Fig. 3a–c) but also genetic blockage down stream from
TLR3 (Fig. 3d). Since other endosomal TLRs e.g. TLR7 and 8
(ssRNA sensors) and TLR9 (sensor for viral and bacterial DNA)
also depend on endosomal acidification and thus could be
inhibited by BFA [45], we blocked TRL3 signaling by transfecting
endocervical epithelial cells with dominant negative (dn) TIR-
domain-containing adaptor inducing interferon-b (TRIF) (Fig. 3d).
TRIF is required for all known signaling pathways downstream
from TLR3, including NFkB [46]. It also acts as an adaptor
protein for TLR4 signaling but is not utilized/required by any
other known TLR including TLR7, 8 and 9 [46]. In the absence
of TLR4, confirmed under our experimental conditions (Fig. 2a),
dnTRIF would specifically inhibit TLR3 signaling only, and in
combination with BFA would provide a solid proof for a TLR3
dependent pathway.
TV isolates from women with symptomatic trichomoniasis were
collected at two clinical sites and analysed for TVV by RT-PCR as
described [17]. Most (13/16 or 81%) of the TV isolates were TVV
positive and most (11/13) carried simultaneously 2 or more TVV
species. Two TVV-negative isolates (OC7 and UH511) and four
TVV-positive isolates (OC4, OC6, OC8 and UH811) were
expanded for immunologic analyses in the presence of BFA and
dnTRIF. Poly(I:C) served as a positive TLR3/TRIF-depedent
control; MALP-2 and LPG (preparations purified from UR1 and
OC6) served as TRL3/TRIF independent proinflammatory
controls.
TLR3-depedent (BFA-suppressed) NF-kB activation (Fig. 3a),
IL-8 (Fig. 3b) and IFNb (Fig. 3c) were induced by poly(I:C) and
the TVV-infected isolates only, but not by MALP-2, LPG and
TVV-negative isolates. Similarly, the expression of dnTRIF
suppressed IL-8 induced by poly(I:C) and all virus-infected
isolates (Fig. 3d).
Antibiotic Treatment as an Amplifier of Inflammatory
Responses to Virus-Inhabited Parasites
Having confirmed that TVV-infected trichomonads trigger a
TLR3/TRIF-depedent proinflammatory reaction, we were con-
cerned that on this biological basis conventional anti-protozoan
antibiotic treatment may amplify inflammatory responses unfa-
vorable to the vaginal mucosal barrier or the reproductive process
via causing increased viral production/shedding by stressed or
dying parasites.
To test this premise we incubated trichomonads in epithelial cell
culture medium supplemented with 100 mM metronidazole or
equivalent (0.1%) solution of DMSO (‘no drug control’). MIC,
defined as the minimum inhibitory concentration of metronidazole
that kills 80% of the protozoa within 24 h [27] ranged between
0.78 and 100 mM for all TV isolates except for OC4 and UH811,
which had MIC .300 mM at 48 h and UH711 (MIC.100 mMa t
24 h and MIC=50 mM at 48 h). The DMSO control had no
effect on the TV motility and survival assessed by a trypan blue
exclusion assay. After 24 h all TV suspensions were cleared from
TV and cellular debris by centrifugation at 10006g for 5 minutes
followed by filtering through 0.45 mm. Filtered supernatants were
added to dnTRIF or control (mcs) epithelial cells for 24 h in the
presence or absence of BFA followed by assessment of cell viability
(MTT assay) and inflammatory mediators (multiplex immunoas-
say).
The results confirmed that in the absence of epithelial
cytotoxicity (Fig. 4a), the supernatants from all metronidazole-
treated TVV-infected trichomonads (but none of the TVV-free
isolates) induced TLR3-dependent (BFA-suppressed) and TRIF-
dependent IL-8 increases (Fig. 4b) and even stronger VSIG
upregulation, including RANTES, MIP-3a, IL-6 and the inter-
cellular adhesion molecule (ICAM)-1 (Fig.4c–f). At the same time
the most proinflammatory supernatants from drug-treated TV
isolates induced TRL3/TRIF-dependent increases in the inflam-
masome-regulated proinflammatory cytokine IL-1b (Fig. 4g), while
none or relatively weaker counter-balancing increases in IL-1
receptor antagonist (IL-1RA) (Fig. 4h), regarded as a major anti-
inflammation factor in the vaginal mucosal environment [47].
IFNb production was also significantly amplified by metronidazole
treatment of all TVV-positive isolates tested (Fig. 5). Interestingly,
cell-free supernatants from the metronidazole resistant OC4 and
UH811, followed by the moderately resistant UH711, induced
higher proinflammatory cytokines and IFNb upregulation at
baseline, still amplified by metronidazole treatment, which could
be explained by a stress-inducible virion shedding or production
and should be further investigated. These results provide evidence
that metronidazole has the potential to cause unwanted inflam-
matory responses via cell-free viral dsRNA released from TVV-
infected TV with various metronidazole sensitivities.
We then argued that by killing drug-sensitive protozoa and thus
reducing the parasite load, metronidazole may counter-balance
the inflammatory reaction triggered by TVV release/production.
To test this premise we infected the endocervical cells expressing
dnTRIF or mcs with the most metronidazole-susceptible TV isolate
(OC6, MIC=0.78 mM) in the presence or absence of metronida-
zole for 24 h (Fig. 6). B7RC2 was used as a TVV-negative control.
Although metronidazole reduced IL-1b response to OC6 possibly
due to decreased protozoan load over the 24 h period, it also
decreased IL-1RA and amplified all TRIF-dependent cytokines/
chemokines suggesting a potential to shift the inflammatory
balance in the reproductive tract mucosa despite efficient parasitic
killing.
Figure 7. Purified Trichomonasvirus (TVV) virions provoke TLR3- and TRIF-dependent inflammatory responses. (A) Transmission
electron micrograph of TVV1 virions isolated from UH9 trichomonads (bar=100 nm). (C) IL-8 and (D) IFNb levels in supernatants from endocervical
epithelial cells transfected with mcs or dnTRF and exposed to B7RC2, UH9, TVV1 and poly(I:C) for 24 h with MTT viability assay (B) performed on the
same cells at the time of supernatant collection. (E) NF-kB activation and (F) IL-8 expressed by endocervical epithelial cells in response to
trichomonads (B7RC2 and UH9), purified virions (TVV1 from UH9), poly(I:C) or MALP-2 in the presence or absence of TLR3 inhibitor BFA. (G) NF-kB
activation, (H) IL-8, (I) RANTES and (J) IFNb production in response to virions (TVV1 from UH9), virion extraction buffer control at equivalent
concentration, poly(I:C) and MALP-12 in the presence or absence of 100 mM metronidazole. Bars represent means and S.E.M. of duplicate (b,c,d) or
triplicate (e,f-h) cultures in two of four independent experiments.
+++p,0.01 and
+++p,0.001, stimulated/infected different from medium control;
*,0.05,
***p,0.001 bafilomycin A1 different from solvent (DMSO) control or dnTRIF different from plasmid control (mcs) (two-way ANOVA,
Bonferroni).
doi:10.1371/journal.pone.0048418.g007
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To generate a direct proof for the pathogenic interaction
between Trichomonasvirus and the human host, we purified intact
TVV1 virions from UH9 (Fig. 7a) and applied in parallel UH9
trichomonads and estimated equivalent purified virions to the
endocervical NF-kB-luciferase reporter cell line in the presence or
absence of BFA, and to the endocervical dnTRIF and mcs
expressing cell lines (Fig. 7b–j). MALP-2, poly(I:C) and live
B7RC2 served as additional controls. Consistent with the results
obtained with intact live trichomonads and metronidazole-treated
trichomonads or their cell-free supernatants, the exposure to
purified virions triggered a TLR3/TRIF-dependent NF-kB
activation (Fig. 7e), IL-8 (Fig. 7c,f), and IFNb (Fig. 7d) suppressed
by both BFA and dnTRIF in the absence of cell toxicity (Fig. 7b).
In another experiment we tested the same TVV1 preparation in
the presence of metronidazole and as expected the drug had no
effect on NF-kB activation (Fig. 7g), IL-8 (Fig. 7h), RANTES
(Fig. 7i) and IFNb (Fig. 7j) production triggered by purified virions
supporting the concept that the antibiotic acts via releasing more
virions/dsRNA from parasites and not via mediating the virion-
host interaction.
To determine if the signal transduction by the metronidazole-
treated TV was triggered by cell-free and virion-free dsRNA or by
intact virions that might be taken up by the epithelial cells we
conducted experiments in the presence of shortcut RNase III. We
first determined that the enzyme was efficient in digesting dsRNA
in our cell culture media (Fig. 8a). Then we determined that the
genomic dsRNA was efficiently protected within the intact virion
preparation used in our study, while it was fully degraded upon its
heat-induced release from the virions (Fig. 8b). The RNase was
Figure 8. Effect of ShortCut RNAse III on TVV dsRNA signaling.
(A) A dose of 2 U/ml efficiently digested purified TVV1 dsRNA: 1=No
Rnase control, 2=Company buffer provided by manufacturer with the
RNase kit, 3=KSFM culture medium, 4=modified Diamond medium.
(B) Comparison of enzymatic effects on intact TVV1 (lanes 1–4) versus
p r e - h e a t e dT V V 1( l a n e s5 – 8 ) :1 ,5 = n oR N a s e ,2 ,6 = 2 0 0 U / m L ,
3,7=20 U/mL, 4,8=2 U/mL of RNase III, all efficiently digesting the
dsRNA but only if released from pre-heated virions. (C)I F N b
measurement in endocervical epithelial cells exposed to medium
(med.), supernatants (sup.) from B7RC2 and UH9 TV isolates treated
with metronidazole or DMSO control, intact virions (UH9 TVV) and
poly(I:C). Bars represent means and S.E.M. of biological triplicates.
***p,0.001, RNase different from medium control (two-way ANOVA,
Bonferroni).
doi:10.1371/journal.pone.0048418.g008
Figure 9. IRF3 phosphorylation in response to T. vaginalis
infection. (A) 1 h stimulation of endocervical epithelial cells:
1=medium control; 2=UH9 virions; 3=B7RC2 live TV, 4=UR1 live TV,
5=UH9 live TV; 6=poly(I:C). (B) 3 h stimulation of endocervical
epithelial cells: 1=medium control, 2=poly(I:C), 3=live UR1 TV,
4=UH9 live TV. (C) Stimulation of vaginal epithelial cells for 1 h (lane
1) and 5 h (lanes 2–6): 1=poly(I:C) control, 2=2medium control,
3=B7RC2 live TV, 4=B7RC2 24 h supernatant, 5=poly(I:C), 6=UH9 live
TV, 7=UH9 24 h supernatant. (D) Endocervical cells were infected with
B7RC2, UR1 and UH9 for 24 h, supernatants from infected cells and
medium control were then transferred to fresh endocervical epithelial
cells for another 5 h: 1=medium control, 2=epithelial cell conditioned
medium, 3=epithelial supernatants post B7RC2 infection; 4=epithelial
supernatants post UR1 infection; 5=epithelial supernatants post UH9
infection. The protein ladders indicate from top to bottom 130.743 kD,
87.91 kD and 42.466 kD. The upper band in each panel represents IRF3
and the lower band represents b-Actin.
doi:10.1371/journal.pone.0048418.g009
Endobiont Protozoan Viruses Impact the Human Host
PLOS ONE | www.plosone.org 12 November 2012 | Volume 7 | Issue 11 | e48418completely nontoxic to the epithelial cells (MTT assay data not
shown) and fully abrogated IFNb induction by poly(I:C). In
contrast, the uprgeulation of IFNb observed in response to purified
virions (UH9-TVV1) and cell-free TV supernatants (UH9) and
amplified by metronidazole was not affected by RNase III
suggesting that the immune response was at least partially
mediated by intact virions and genomic dsRNA rather than
virion-free dsRNA (Fig. 8c). Supernatants collected from the
TVV-negative isolate B7RC2 with and without metronidazole
treatment failed to induce this pattern (Fig. 8c).
Signaling via Interferon Regulatory Factor 3 (IRF3)
To further elucidate mechanisms of TVV signaling we
investigated IRF3, which is a member of the interferon regulatory
transcription factor family. Its serine/threonine C-terminal cluster
phosphorylation downstream from TLR3 and TRIF activates the
transcription of IFNb, as well as other virus-stress inducible genes.
Both poly(I:C) and purified virions induced a rapid phosphoryla-
tion of IRF3 within 1 hour of endocervical cell stimulation (Fig. 9a).
IRF3 phosphoprotein was detected at 3–5 hours post TV infection
with the TVV-positive but not with TVV negative trichomonads
(Fig. 9b,c). IRF-3 was equally activated by live trichomonds and by
cell-free TV supernatants collected after 24 h culture (Fig. 9c).
IRF3 phosphorylation was induced also by cell-free epithelial
supernatants collected 24 h after endocervical cell infection with
TVV-positive but not TVV-negative parasites (Fig. 9d).
New Outlook of Protozoan Virulence and Potential
Clinical Implications
The results of this investigation support the novel concept that
protozoan endobiont viruses and viral dsRNA sensors of the
human host represent a critical target for modifying the
inflammatory reaction to parasitic infection. Importantly they
provide a plausible biological explanation for inflammatory
complications and apparent failures of conventional parasitologic
treatment for T. vaginalis. Figure 10 summarizes our findings and
hypothesis, implicating TVV virions and dsRNA in TLR3
upregulation, signaling and reproductive tract inflammation, and
at the same time identifies gaps in our knowledge and
understanding of TV virulence. While the roles of multiple
transcription factors and some TLRs have been previously charted
in TV signaling via LPG and TV proteins (reviewed in [3]), the
host receptors for these virulence factors are still enigmatic.
Although the effective suppression of TVV-induced inflammation
by dnTRIF suggests lesser involvement of cytosolic receptors and
TVV capsid proteins, their roles in the context of TVV-inhabited
Figure 10. Model of T. vaginalis virulence and Trichomonasvirus (TVV) interaction with the human host. The protozoan parasite adherent
to the human epithelial cells signals via its major surface lipophosphoglycan (LPG) [22] and one or more still unknown host receptors triggering NF-
kB and other previously identified proinflammatory signal transduction pathways (ERK1/2, MEK1/2, AP-1, p38 and JNK) [23]. Protozoan proteins and
nucleic acids may also signal to the human host although the latter has not been shown. This study demonstrates for the first time that genomic
dsRNA and purified virions from TVV-inhabited trichomonads trigger NF-kB activation, proinflammatory mediators and interferon Type 1 via
endosomal TLR3/TRIF-dependent pathways upstream from Interferon regulatory factor (IRF) 3. We also demonstrate that anti-protozoan antibiotic
treatment (metronidazole) exaggerates the proinflammatory responses e.g. NF-kB, IL-8, and prototype virus stress inducible genes e.g. IFNb, RANTES,
IL-6, MIP-3a and ICAM-1. The mode of TVV entry or TVV dsRNA transfer to the human host and the role of cytosolic host receptors and kinases (e.g.
Nod-like receptors, NLR, RIG-I-like receptors, RLR, and interferon-induced dsRNA-dependent protein kinase, PKR) remain to be elucidated.
doi:10.1371/journal.pone.0048418.g010
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studies should elucidate multiple mechanisms by which TVV
effects could be transmitted to the human host including but not
limited to release of free virions from dying or stressed protozoa,
endocytosis of the free virions and release of free dsRNA upon
virion disruption along endo/lysosomal pathways. Another
possibility would be receptor-mediated virion entry or protozoan
attachment-dependent virion transfer from TV to human cells.
Studies by Alderete and colleagues have suggested that the TVV
genome may mediate human innate and adaptive immune
responses by regulating the expression of protozoan virulence
factors [48]. And finally, clinical studies ate needed to bear out the
link between TVV-exaggerated inflammation, symptom dispari-
ties and trichomoniasis-attributable disease.
A recent study of Leishmaniavirus in a mouse model of
mucocutaneous leishmaniasis generated the first experimental
evidence that endobiont protozoan viruses per se may control the
severity of mammalian parasitic disease [49]. Our investigation is
the first to confirm this general concept in a human infection
model. Studies to correlate Trichomonasvirus with severity of human
disease have been hampered by the limited knowledge of TVV
genetics and hence limited diagnostic and analytical tools.
Nevertheless, in a study of adolescents with T. vaginalis infection,
clinical symptoms e.g. vaginal discharge, dysuria, dyspareunia, and
cervical erythema were significantly associated with TVV-positive
status of the vaginal TV isolates, detectable by nucleic acids gel
electrophoresis [50]. More efficient and cost-effective diagnostics
and surrogate biomarkers are urgently needed for further clinical
observational and interventional studies.
The amplified NF-kB activation and proinflammatory viral
stress-inducible gene expression, triggered by TVV-infected
trichomonads, raise concerns about increased risk of inflamma-
tion-facilitated disorders and risks such as sexual transmission of
HIV. The mucosal inflammatory reaction in the cervicovaginal
environment is a double-edged sword. Being an important part of
the host innate immunity, it may contribute to self-clearance of
low-burden viral, bacterial, fungal and protozoan infections;
however, the inflammatory damage in severe acute or prolonged
inflammation may exceed the benefit. All inflammatory mediators
amplified by TVV play critical and multiple roles in the HIV
pathogenesis. NF-kB activation and expression of IL-1b, IL-6 and
IL-8 drive viral replication through the HIV long-terminal repeat
promoter and IL-8 and ICAM-1 facilitate the recruitment of
inflammatory cells to the inflamed mucosa thus contributing to
inflammatory damage [51,52]. MIP-3a has some anti-viral
properties but it also attracts dendritic cells responsible for the
capture and transport of HIV across the genital tract epithelium
[53]. Although RANTES may compete with HIV for the HIV co-
receptor CCR5 [54], this potentially protective role may be
countered by the extremely potent RANTES-driven recruitment
of CD4-positive HIV host cells to the cevicovaginal mucosal
surface [52]. Increased RANTES levels have been associated with
higher HIV-1 viral load in genital secretions [55] and with rapid
progression to AIDS following serocoenversion [56].
Perhaps the most concerning result from our study is the
potential of TVV-infected TV to enhance the risk of inflamma-
tion-associated reproductive disease if managed as currently. The
endocervical uterine cells responded to TVV and to metronidazole
treatment of TVV-infected trichomonads with enhanced TRIF-
mediated IL-8, MIP-3a, ICAM-1, IL-1b, IL-6, IFNb and
RANTES and reduced levels of IL-1RA, which has a protective
anti-inflammatory role [52]. The presence of TVV per se did not
render TV metronidazole-resistance in our study and in previous
published reports [57,58] and thus, the enhanced inflammatory
reaction to metronidazole-susceptible strains poses special thera-
peutic challenges. Increased levels of inflammatory cytokines and
chemokines have been found in the cervical and vaginal secretions
of women with trichomoniasis [3], and some have prognostic value
in women with preterm delivery [59,60]. On the other hand
placental inflammation is associated with inflammatory responses
in the fetus and especially in extremely low gestation age
newborns, which has been independently linked to a wide range
of frequently occurring developmental problems in this clinical
population [61,62].
Although metronidazole has been FDA approved for TV
treatment since 1963 and tinidazole since 2004, limited informa-
tion is available about their impact on the reproductive tract
immunity and the mucosal barrier and even less is known about
the potential impact of metronidazole treatment on undiagnosed
TV in subjects treated for BV or other anaerobe or protozoan
infections. In addition to T. vaginalis, metronidazole and tinidazole
are used to treat BV, which is frequently accompanied by TV or
sometimes trichomoniasis is misdiagnosed as BV, thus raising
concerns about BV treatment amplifying inflammatory responses
to undiagnosed TVV-infected TV in subjects unaware of their
risks. Metronidazole is also used to treat other protozoan infections
e.g. amebiasis (Entamoeba histolytica, Dientamoeba fragilis, Entamoeba
polecki) and giardiasis (Giardia lamblia, which also carries endobiont
dsRNA viruses).
It is unclear how the antibiotic dose and regimen may affect the
inflammatory reaction to trichomoniasis in the context of TVV-
infected parasites. Metronidazole is available for oral, intravenous,
intravaginal and other topical applications. It has a low serum
protein binding capacity (10%) and it is easily taken up by most
tissues, as well as vaginal and seminal fluids, where it remains
inactive until it enters pathogens capable of ionizing it, leading to
disruption of the pathogen’s DNA [63]. The metronidazole dose
used in our experimental model (100 mM) falls well within the
range of serum concentrations (4.6–45 mg/ml=27–263 mM)
measurable 1–3 hours after the typical oral administration of
250 mg - 2 g metronidazole [64]. At 100 mM all TVV-positive
isolates tested in our study elicited TLR3/TRIF-dependent
inflammatory responses by the cervicovaginal epithelium. It is
unknown whether under clinical conditions a high-dose one-time
treatment would induce a transient pro-inflammatory flare
weakening the vaginal barrier and whether an extended albeit
lower dose regimen may reduce the inflammatory reaction or
cause a prolonged chronic inflammation thus necessitating
modified protective behavior or interventions. It is also unclear
how such inflammatory responses may translate into pregnancy
disorders.
Currently, metronidazole is classified by FDA as a category B
pregnancy risk mostly due to lack of adequate studies and the
treatment guidelines for trichomoniasis treatment in pregnancy
are controversial. While the CDC recommends the typical oral 2 g
treatment in any stage of pregnancy, the manufacturer warns
against first trimester use. For BV, the general recommendation is
to avoid metronidazole in the first trimester and then treat with
lower oral doses (up to 1 g daily) regardless of premature delivery
risk factors. It is conceivable that virus released by dying protozoa
during conventional antibiotic treatment fuels pathogenic inflam-
matory responses linked to preterm birth and facilitating risk of
HIV and other STIs.
Conclusions
Protozoan endobiont viruses can be sensed by the human host
and should be further studied as critical targets for modifying
therapeutic paradigms and prevention of inflammatory sequelae
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Focused clinical investigations are needed to assess the potential
adverse effects on the innate immune barrier in the reproductive
tract of pregnant and non-pregnant women. Innovative approach-
es targeting TVV viral load in the TVV-inhabited parasites alone
or combined with anti-inflammatory agents may yield improved
outcomes. Future translational research in this direction may lead
to a much needed paradigm shift in prevention and therapy of the
most common curable sexually transmitted infection and its
inflammatory sequelae.
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